Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mark M. Sieczkarek currently holds 1,156,883 shares of NovaBay Pharmaceuticals, Inc. (NBY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark M. Sieczkarek has been a net seller of NBY stock. They have purchased $387.3K and sold $6.0M worth of shares.
Mark M. Sieczkarek's most recent insider trade was on Jul 30, 2019, when they sold 167,938 shares at $0.00 per share.
Mark M. Sieczkarek serves as Executive at NovaBay Pharmaceuticals, Inc. (NBY). They have executed 61 insider transactions totaling $6.4M over their tenure at the company.
Mark M. Sieczkarek holds the position of Executive at NovaBay Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Mark M. Sieczkarek has shown a selling trading pattern, with $387.3K in total purchases and $6.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Mark M. Sieczkarek was on Jan 20, 2010, when they sold $2.0M worth of CPTS shares. This transaction involved 98,311 shares at $20.00 per share.
Mark M. Sieczkarek currently owns 1,156,883 shares of NovaBay Pharmaceuticals, Inc. (NBY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mark M. Sieczkarek's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mark M. Sieczkarek has 61 Form 4 filings on record as an insider at NovaBay Pharmaceuticals, Inc..
Set alerts for Mark M. Sieczkarek and 40,000+ other insiders.